Clicky

KalVista Pharmaceuticals Inc(4XC1) News

Date Title
Apr 8 KalVista licenses commercialisation rights for HAE to Kaken in Japan
Apr 8 KalVista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical to Commercialize Sebetralstat for HAE in Japan
Mar 12 KalVista Pharmaceuticals Reports Third Fiscal Quarter Results and Provides Operational Update
Mar 10 KalVista Pharmaceuticals to Host Investor Webcast Highlighting Commercialization Strategy, Plans and Progress for Sebetralstat in Hereditary Angioedema
Feb 21 KalVista Pharmaceuticals to Present New Sebetralstat Data at the American Academy of Allergy, Asthma & Immunology 2025 Annual Meeting